Skip links

SAJAZIR™ (icatibant)

Full Name SAJAZIR™ (icatibant)
Drug Sajazir
Manufacturer Cycle Pharmaceuticals
Route of Administration Subcutaneous
Site of Care Home or Healthcare Facility
Approved Indication The treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older
Disease Hereditary Angioedema (HAE)
Therapeutic Area Allergy & Immunology
Enrollment Form Link Enrollment Form
Phone Number (800) 356-4252
Fax Number (877) 2777318
Product Website sajazir.com/hcp/